• Only FDA approved oral solution for the prophylactic treatment of gout flares in adults
  • 0.6mg/5mL Colchicine
  • Liquid dosage form provides dosing flexibility
Learn More

Gout: A Growing Problem

  • Gout affects 8.3 million people in the United States.
  • Many patients remain undiagnosed due to limited disease awareness
  • Gout patient numbers are expected to increase due to the aging population
Learn More
  • Only FDA approved oral solution for the prophylactic treatment of gout flares in adults
  • 0.6mg/5mL Colchicine
  • Liquid dosage form provides dosing flexibility
Learn More

Gout: A Global Problem

  • Gout affects 8.3 million people in the United States.
  • Many patients remain undiagnosed due to limited disease awareness
  • Gout patient numbers are expected to increase due to the aging population
Learn More
  • Only FDA approved oral solution for the prophylactic treatment of gout flares in adults
  • 0.6mg/5mL Colchicine
  • Liquid dosage form provides dosing flexibility
Learn More

Gout: A Global Problem

  • Gout affects 8.3 million people in the United States.
  • Many patients remain undiagnosed due to limited disease awareness
  • Gout patient numbers are expected to increase due to the aging population
Learn More

ROMEG News

FDA Approval for Gloperba

FDA Approval for Gloperba

JANUARY 30, 2019

Patent Allowance

DECEMBER 12, 2018

Patent issued

MARCH 6, 2018